Biocardia Inc (BCDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,650 | -3,913 | -2,267 | -11,571 | -9,499 |
| Depreciation Amortization | 52 | 36 | 19 | 84 | 64 |
| Accounts receivable | 87 | 87 | 29 | 115 | 86 |
| Other Working Capital | -654 | 505 | 451 | 129 | 209 |
| Other Operating Activity | 712 | 443 | 238 | 1,269 | 1,017 |
| Operating Cash Flow | $-5,453 | $-2,842 | $-1,530 | $-9,974 | $-8,123 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -3 | N/A | -12 | -12 |
| Investing Cash Flow | $-5 | $-3 | $N/A | $-12 | $-12 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,513 | 3,315 | 1,466 | 4,388 | 3,042 |
| Other Financing Activity | -1,228 | -152 | -90 | -662 | -435 |
| Financing Cash Flow | $9,285 | $3,163 | $1,376 | $3,726 | $2,607 |
| Beginning Cash Position | 1,103 | 1,103 | 1,103 | 7,363 | 7,363 |
| End Cash Position | 4,930 | 1,421 | 949 | 1,103 | 1,835 |
| Net Cash Flow | $3,827 | $318 | $-154 | $-6,260 | $-5,528 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,453 | -2,842 | -1,530 | -9,974 | -8,123 |
| Capital Expenditure | -5 | -3 | N/A | -12 | -12 |
| Free Cash Flow | -5,458 | -2,845 | -1,530 | -9,986 | -8,135 |